Greece
BECRO is an independent contract services organization (CRO) founded in 2010 by professionals with a wealth of experience in drug development and regulation. The team comprises former officials from Regulatory Agencies, the Industry, and Academics, as well as experts in clinical trials, pharmacokinetics, biostatistics, and data management.
Based in Greece, BECRO offers critical services to the pharmaceutical industry, addressing the growing demand for specialized drug development expertise. With its strong team and extensive experience, the company is well-positioned to make significant contributions to the field of pharmaceuticals, particularly in the areas of regulation, clinical trials, and data management.
Despite the absence of specific information regarding the last investment and investors, BECRO's foundational strengths and the increasing importance of its services in the pharmaceutical sector make it an attractive prospect for potential venture capital investment. As the company continues to expand and solidify its position in the industry, venture capitalists should carefully monitor its growth and consider the potential for strategic investment and collaboration.
